Related Articles
Influence of autologous dendritic cells on cytokine‑induced killer cell proliferation, cell phenotype and antitumor activity in vitro
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old
Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation
Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer
Enhanced antitumor effects and improved immune status of dendritic cell and cytokine‑induced killer cell infusion in advanced cancer patients